Media alert

Geleen, NL, 14 November 2022 10:00 CET

Today Envalior announces a new strategic partnership with Compounding Solutions, a global leader in high quality custom thermoplastic medical grade compounds and concentrates. This strategic partnership provides medical device customers with streamlined access to Envalior’s Care portfolio, including Arnitel® Care, recognized as a superior alternative to existing catheter materials. Additionally, medical device companies will speed their time to market through Compounding Solutions efficient catheter material customization, quick development turnaround time and reliability of supply.

Major medical device OEMs require custom colors, radiopacifies, lubricants and other additives. Through this new partnership with Compounding Solutions, Envalior will have the ability to meet this demand.

“The synergies from this partnership will enable further innovation with our Care line of medical grade materials,” says Andre Oosterlaken, Global Market Development Manager for Medical Devices. “The goal is to reduce the time to market for our medical device customers with high-quality custom compounds made from DEM’s Care products, and ultimately bring next generation material solutions that will have a positive impact on patient outcomes.”

Oosterlaken adds, “Compounding Solutions is the natural partner for us because of their extensive experience and expertise in compounding a wide range of medical grade materials, especially materials which are extruded for various vascular catheter applications.”

“Since 1999 we have been focused on the highest quality custom medical compounds for vascular catheter tubing since achieving optimal dispersion with high additive loadings is extremely difficult,” says Scott Neal, General Manager of Compounding Solutions. “We are always excited to see innovative medical materials brought to this market, such as the Arnitel® Care line from Envalior, which has the ability to provide significant processing and clinical advantages to the next generation of vascular catheters.”

Envalior’ Arnitel® Care portfolio offers a full line of innovative medical materials for vascular catheters. These materials have been designed, engineered, and tested to the highest quality and certification standards.

Manufacturing benefits include:

•  Improved extrusion predictability and efficiency compared to commonly used catheter materials
• Easily welded or glued to many other materials and itself, increasing overall strength and reducing potential failures
• Predictable, consistent shrinkage during reflow processes
• Less dimensional change with annealing
• Gel-Free extrusion, reduces scrap, improves product quality, and eliminates risk of bond point failures

Clinical benefits include:

• Easy and predictable extrusion and secondary assembly reducing potential for clinical failures
• Stiffness is independent of moisture absorption, so catheters perform the same in all humidity environments
• Best in class Energy Loss Factor compared to alternatives, enabling better snap back/memory and kink resistance performance